NIH ‘High Risk-High Reward’ grants go to researchers exploring strategies to fight cancer and other diseases
Thomas Kodadek, Ph.D., and Mohammed Gbadamosi, Ph.D., received High Risk-High Reward grants from the National Institutes of Health.
Thomas Kodadek, Ph.D., and Mohammed Gbadamosi, Ph.D., received High Risk-High Reward grants from the National Institutes of Health.
The project aims to better understand the benefits and harms of medical marijuana in patients with breast cancer.
The project aims to understand the molecular mechanisms of how different classes of estrogen receptor antagonists inhibit breast cancer growth.
The projects reflect the center’s multidisciplinary, collaborative approach to cancer research.
The grant funds a study of strategies to restore the function of aging blood vessels and stem cells.
The long-term goal of the study is to develop a therapy to target treatment-refractory breast cancers.
The study will explore the potential for kava to serve as a tobacco cessation aid.
The researchers will identify geographic hotspots of low adherence to lung cancer screening in veterans.
The study will explore how tumor cells avoid targeting from the immune system.
The team will study microRNA degradation and explore how the process enhances the killing of T-ALL cells during chemotherapy.